59 min listen
Episode 77
FromBiotech Hangout
ratings:
Length:
58 minutes
Released:
Oct 25, 2023
Format:
Podcast episode
Description
Guests Jacob Plieth, Madeleine Armstrong and Nuvalent CEO, Jim Porter join Daphne Zohar and Josh Schimmer on this week’s Biotech Hangout to discuss the big deal of the week: Merck and Daichii’s co-development & co-commercialization deal for three ADCs (worth up to $16.5B), plus Nuvalent’s $300M raise and recent data. They also discuss the recent ESMO data breach, PTC Therapeutics’ agreement with Royalty Pharma and Monte Rosa’s partnership with Roche. Other topics include Revolution Medicines’ KRAS data, the FDA’s decision to clear Nkarta’s IND application, Pfizer’s revenue guidance related to Covid products and overall CEO and industry sentiment. *This episode aired on October 20, 2023
Released:
Oct 25, 2023
Format:
Podcast episode
Titles in the series (72)
Episode 36 by Biotech Hangout